Haoqian Li

Relationship between PD-L1 expression and [18F]FAPI versus [18F]FDG uptake on PET/CT in lung cancer

Jingjie Qin, Chao Han, Haoqian Li, Zhendan Wang et autres

cn (code pays fourni par la source)

Efficacy and safety of anti-programmed death-1 antibody-based combination therapy in advanced or metastatic gastric or gastroesophageal junction cancer in Chinese patients: A real-world study

Yifan Gao, Haoqian Li, Lei Qiu, Hongtu Yuan et autres

PURPOSE: Programmed death-1 antibody plus chemotherapy has gained approval for the treatment for (human epidermal growth factor receptor 2 negative locally advanced or metastatic gastric or gastroesophageal junction cancer. This study aims to analyze the efficacy and safety of anti-programmed death-1 antibody …

cn (code pays fourni par la source)

Development and Validation of Nomograms for Predicting Pneumonia in Patients with COVID-19 and Lung Cancer

Yiyue Xu, Haoqian Li, Xiaoqing Wang, Butuo Li et autres

Background: COVID-19 has spread worldwide, becoming a global threat to public health and can lead to complications, especially pneumonia, which can be life-threatening. However, in lung cancer patients, the prediction of pneumonia and severe pneumonia has not been studied. We aimed to …

cn (code pays fourni par la source)

Pulmonary sarcoidosis-like reactions induced by sintilimab in esophageal cancer: A case report

Haoqian Li, Fengchun Mu, Bing Yu Zou, Linlin Wang

RATIONALE: Esophageal cancer is one of the deadliest cancers in the world, with high incidence and mortality rates ranking among the top ten in China. The efficacy of conventional treatments is limited and often accompanied by severe adverse reactions, which results in …

cn (code pays fourni par la source)

Efficacy and safety of PD-1/PD-L1 inhibitor plus platinum-based chemotherapy vs. platinum-based chemotherapy alone in patients with previously untreated advanced large-cell neuroendocrine cancer of the lung.

Fengchun Mu, Bingjie Fan, Haoqian Li, Taotao Dong et autres

9066 Background: Large-cell neuroendocrine carcinoma (LCNEC) is a rare tumor with a poor prognosis and limited treatment options. The efficacy of first-line therapies for LCNEC has not yet been established. This study evaluated the efficacy and safety of the combination of PD-1/PD-L1 …

cn (code pays fourni par la source)

Impact of Nab-Paclitaxel Plus PD-1/PD-L1 Inhibitor on Chemorefractory Relapsed Small-Cell Lung Cancer

Fengchun Mu, Bingjie Fan, Haoqian Li, Wenru Qin et autres

Background: The present study evaluated the efficacy and safety of nab-paclitaxel (nab-PTX) with a concurrent PD-1/PD-L1 inhibitor in patients with refractory relapsed small-cell lung cancer (SCLC). Patients & methods: We retrospectively analyzed 240 patients with refractory relapsed SCLC: 40 patients were treated …

cn (code pays fourni par la source)

Comparison of the Incidence Rate of Radiation Pneumonitis Observed in Patients with Advanced Lung Adenocarcinoma Treated with Simultaneous Thoracic Radiotherapy and 1G/2G/3G EGFR-TKIs

Bingjie Fan, Fengchun Mu, Butuo Li, Wenru Qin et autres

Abstract Background: The present study aimed to evaluate the incidence rate of radiation pneumonitis (RP) in patients with stage III-IV lung adenocarcinoma treated with first-generation (1G), second-generation (2G), or third-generation (3G) epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) combined with thoracic …

gb, cn (code pays fourni par la source)